These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling. Shin H; Kim JH; Lee YS; Lee YC Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241 [TBL] [Abstract][Full Text] [Related]
5. Compound K, a metabolite of ginseng saponin, inhibits colorectal cancer cell growth and induces apoptosis through inhibition of histone deacetylase activity. Kang KA; Piao MJ; Kim KC; Zheng J; Yao CW; Cha JW; Kim HS; Kim DH; Bae SC; Hyun JW Int J Oncol; 2013 Dec; 43(6):1907-14. PubMed ID: 24100442 [TBL] [Abstract][Full Text] [Related]
6. Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression. Zaikos TD; Painter MM; Sebastian Kettinger NT; Terry VH; Collins KL J Virol; 2018 Mar; 92(6):. PubMed ID: 29298886 [TBL] [Abstract][Full Text] [Related]
7. Novel β-Carboline/Hydroxamic Acid Hybrids Targeting Both Histone Deacetylase and DNA Display High Anticancer Activity via Regulation of the p53 Signaling Pathway. Ling Y; Xu C; Luo L; Cao J; Feng J; Xue Y; Zhu Q; Ju C; Li F; Zhang Y; Zhang Y; Ling X J Med Chem; 2015 Dec; 58(23):9214-27. PubMed ID: 26555243 [TBL] [Abstract][Full Text] [Related]
8. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA). Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525 [TBL] [Abstract][Full Text] [Related]
9. The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways. Meng J; Zhang HH; Zhou CX; Li C; Zhang F; Mei QB Oncol Rep; 2012 Jul; 28(1):384-8. PubMed ID: 22552631 [TBL] [Abstract][Full Text] [Related]
10. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression. Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840 [TBL] [Abstract][Full Text] [Related]
11. Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells. Xiong H; Du W; Zhang YJ; Hong J; Su WY; Tang JT; Wang YC; Lu R; Fang JY Mol Carcinog; 2012 Feb; 51(2):174-84. PubMed ID: 21520296 [TBL] [Abstract][Full Text] [Related]
12. [Histone deacetylase inhibitors - molecular mechanisms of actions and clinical applications]. Grabarska A; Dmoszyńska-Graniczka M; Nowosadzka E; Stepulak A Postepy Hig Med Dosw (Online); 2013 Aug; 67():722-35. PubMed ID: 24018438 [TBL] [Abstract][Full Text] [Related]
13. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo. Weichert W; Röske A; Niesporek S; Noske A; Buckendahl AC; Dietel M; Gekeler V; Boehm M; Beckers T; Denkert C Clin Cancer Res; 2008 Mar; 14(6):1669-77. PubMed ID: 18347167 [TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors induce cell death selectively in cells that harbor activated kRasV12: The role of signal transducers and activators of transcription 1 and p21. Klampfer L; Huang J; Shirasawa S; Sasazuki T; Augenlicht L Cancer Res; 2007 Sep; 67(18):8477-85. PubMed ID: 17875686 [TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging. Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936 [TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells. Sonnemann J; Kumar KS; Heesch S; Müller C; Hartwig C; Maass M; Bader P; Beck JF Int J Oncol; 2006 Mar; 28(3):755-66. PubMed ID: 16465382 [TBL] [Abstract][Full Text] [Related]
17. Targeting histone deacetylases for the treatment of cancer and inflammatory diseases. Huang L J Cell Physiol; 2006 Dec; 209(3):611-6. PubMed ID: 17001696 [TBL] [Abstract][Full Text] [Related]
18. A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells. Patra N; De U; Kim TH; Lee YJ; Ahn MY; Kim ND; Yoon JH; Choi WS; Moon HR; Lee BM; Kim HS Biomed Pharmacother; 2013 Jun; 67(5):407-15. PubMed ID: 23583193 [TBL] [Abstract][Full Text] [Related]
19. HDAC inhibitor-based therapies: can we interpret the code? New M; Olzscha H; La Thangue NB Mol Oncol; 2012 Dec; 6(6):637-56. PubMed ID: 23141799 [TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors promote the tumoricidal effect of HAMLET. Brest P; Gustafsson M; Mossberg AK; Gustafsson L; Duringer C; Hamiche A; Svanborg C Cancer Res; 2007 Dec; 67(23):11327-34. PubMed ID: 18056459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]